Generative Ai

1 article

Holographic molecular models and AI interfaces in a futuristic lab, representing accelerated drug discovery and in silico trials.

AI Drug Development Market Surges as In Silico Trials Promise Major Efficiency Gains

The AI drug development market is experiencing dramatic growth, with in silico trials poised to significantly reduce research timelines and costs. While investment and data availability fuel this expansion, challenges in data integration and regulatory frameworks persist.

Aram Sarkisian·June 6, 2026